Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report / Diral, E.; Catalano, G.; Cicinelli, M. V.; Distefano, A.; Mastaglio, S.; Vago, L.; Lupo Stanghellini, M. T.; Bernardi, M.; Ponzoni, M.; Ciceri, F.; Carrabba, M. G.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 14:(2024). [10.3389/fonc.2024.1399894]

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

Cicinelli M. V.;Distefano A.;Vago L.;Ponzoni M.;Ciceri F.
Penultimo
;
2024-01-01

Abstract

Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment. We report a case of choroidal involvement in a woman affected by CMML and presenting only with visual impairment. The patient was initially evaluated for an intensive therapeutic approach, but after biopsy the ocular lesion spontaneously regressed. Thus a “watch and wait” strategy was preferred. One year and a half after initial diagnosis, the patient is alive, with stable hematological disease and without any ocular involvement. Therefore, a close, not invasive follow up could be useful to tailor treatment for patients affected by single ocular lesions in CMML.
2024
chronic myelomonocytic leukemia
multimodal imaging analysis
ocular involvement
personalized medicine
watch and wait approach
File in questo prodotto:
File Dimensione Formato  
fonc-14-1399894.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 401.12 kB
Formato Adobe PDF
401.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/164919
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact